Evidence map›Paper›PMID 40906491›Full record

ArticleThe American journal of drug and alcohol abuse2025

Associations between COVID impact domains and time to buprenorphine treatment disengagement.

Zoe M Weinstein, Kara M Magane, Sara Lodi, Delilah Doeleman, Alicia S Ventura, Angela R Bazzi, Melissa Davoust, Margaret G Shea, Clara A Chen, Anna Cheng and 3 more

Abstract read
In one paragraph

Article in The American journal of drug and alcohol abuse, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zoe M WeinsteinGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Massachusetts, Boston, USA.
Kara M MaganeDepartment of Community Health Sciences, Boston University School of Public Health, Massachusetts, Boston, USA.
Sara LodiDepartment of Biostatistics, Boston University School of Public Health, Massachusetts, Boston, USA.
Delilah DoelemanDepartment of Health Law, Policy and Management, Boston University School of Public Health, Massachusetts, Boston, USA.
Alicia S VenturaGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Massachusetts, Boston, USA.
Angela R BazziDepartment of Community Health Sciences, Boston University School of Public Health, Massachusetts, Boston, USA.
Melissa DavoustDepartment of Health Law, Policy and Management, Boston University School of Public Health, Massachusetts, Boston, USA.
Margaret G SheaCenter for Health Data Science (CHDS), Massachusetts, Boston, USA.
Clara A ChenCenter for Health Data Science (CHDS), Massachusetts, Boston, USA.
Anna ChengBoston University Chobanian & Avedisian School of Medicine, Massachusetts, Boston, USA.
Jacqueline TheisenBoston University Chobanian & Avedisian School of Medicine, Massachusetts, Boston, USA.
Samantha BlakemoreGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Massachusetts, Boston, USA.
Richard SaitzDepartment of Community Health Sciences, Boston University School of Public Health, Massachusetts, Boston, USA.

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Preventing HIV infection among people who inject drugs during COVID-19K01DA043412 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON · 2017 to 2021
$934k
NCATS NIH HHS UL1 TR001430NIDA NIH HHS K01 DA043412
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BuprenorphineCOVID-19Opiate Substitution TreatmentOpioid-Related DisordersTime-to-TreatmentAdultFemaleHealth Services AccessibilityHumansMaleMiddle AgedProspective StudiesBuprenorphineambulatory careBuprenorphineCOVID-19Opioid-related disorderspandemic

Identifiers

PMID40906491
PMCPMC12720390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.